Joint pain and falls among women with breast cancer on aromatase inhibitors

被引：0
|
作者：
Coby Basal
Emily Vertosick
Theresa A. Gillis
Qing Li
Ting Bao
Andrew Vickers
Jun J. Mao
机构：
[1] Memorial Sloan Kettering Cancer Center,Medicine
[2] Memorial Sloan Kettering Cancer Center,Epidemiology and Biostatistics
[3] Memorial Sloan Kettering Cancer Center,Neurology
[4] Bendheim Integrative Medicine Center,undefined
来源：
Supportive Care in Cancer | 2019年 / 27卷
关键词：
Breast cancer; Aromatase inhibitors; Fall risk; Arthralgia; Joint pain; Falls;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2195 / 2202
页数：7
相关论文
共 50 条
  • [21] Prevalence of bisphosphonate therapy in women with breast cancer treated with aromatase inhibitors in Germany
    Jacob, Louis
    Kostev, Karel
    Hadji, Peyman
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2017, 55 (05) : 394 - 396
  • [22] Ovarian stimulation and fertility preservation with the use of aromatase inhibitors in women with breast cancer
    Reddy, Jhansi
    Oktay, Kutluk
    FERTILITY AND STERILITY, 2012, 98 (06) : 1363 - 1369
  • [23] Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer
    Rebecca L. Sedjo
    Scott Devine
    Breast Cancer Research and Treatment, 2011, 125 : 191 - 200
  • [24] Predictors of non-adherence to aromatase inhibitors among commercially insured women with breast cancer
    Sedjo, Rebecca L.
    Devine, Scott
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (01) : 191 - 200
  • [25] Prevalence and risk factors for insomnia among breast cancer patients on aromatase inhibitors
    Krupali Desai
    Jun J. Mao
    Irene Su
    Angela DeMichele
    Qing Li
    Sharon X. Xie
    Philip R. Gehrman
    Supportive Care in Cancer, 2013, 21 : 43 - 51
  • [26] Efficacy of antiobesity medications among breast cancer survivors taking aromatase inhibitors
    Fansa, Sima
    Ghusn, Wissam
    Tama, Elif
    Nicolalde, Bryan
    Anazco, Diego
    Andre, Stacy D. '
    Faubion, Stephanie S.
    Shufelt, Chrisandra L.
    Acosta, Andres
    Andrade, Maria D. Hurtado
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 208 (03) : 553 - 563
  • [27] Prevalence and risk factors for fatigue among breast cancer survivors on aromatase inhibitors
    Mao, Huijuan
    Bao, Ting
    Shen, Xueyong
    Li, Qing
    Seluzicki, Christina
    Im, Eun-Ok
    Mao, Jun J.
    EUROPEAN JOURNAL OF CANCER, 2018, 101 : 47 - 54
  • [28] Aromatase inhibitors in breast cancer
    Hiscox, Stephen
    Davies, Eleri Lloyd
    Barrett-Lee, Peter
    MATURITAS, 2009, 63 (04) : 275 - 279
  • [29] Aromatase inhibitors for breast cancer
    Susanne Briest
    Nancy E. Davidson
    Reviews in Endocrine and Metabolic Disorders, 2007, 8 : 215 - 228
  • [30] Prevalence and risk factors for insomnia among breast cancer patients on aromatase inhibitors
    Desai, Krupali
    Mao, Jun J.
    Su, Irene
    DeMichele, Angela
    Li, Qing
    Xie, Sharon X.
    Gehrman, Philip R.
    SUPPORTIVE CARE IN CANCER, 2013, 21 (01) : 43 - 51
12345